Decoding Tumor Genomics at the Tissue Level
Solid biopsy testing at DNA GTx applies advanced genomic technologies to directly analyze tumor tissue and uncover the molecular drivers of cancer. By interrogating DNA from tissue samples, this approach provides a comprehensive view of somatic alterations within the tumor microenvironment. The resulting high-resolution genomic insights support accurate diagnosis, prognostic stratification, and informed selection of targeted therapies, enabling precision treatment decisions.
Nos services
Precision Profiling for Personalized Oncology
Solid biopsy testing analyzes DNA from tumor tissue sample to characterize cancer-associated genetic alterations. This high-depth tissue-based approach provides detailed insights into tumor biology, supporting accurate diagnosis, and personalized treatment planning.
Gain Clarity in Cancer Care:
Reveal Tumor-Specific Mutations
- Detect genetic alterations driving tumor growth, including rare and complex variants.
Guide Targeted Therapies
- Support personalized treatment plans by matching patients to therapies based on their tumor profile.
Caractéristiques:
- Covers a wide range of genes associated with cancer-related alterations
- Next-generation sequencing (NGS) for detection of SNVs, indels, CNVs, gene fusions, and MSI/TMB
- Tissue based testing
- Clinically actionable reports aligned with ACMG and AMP guidelines
- Matched therapy and clinical trial insights to support precision treatment decisions
Résultats
- Informed treatment selection with targeted therapy and immunotherapy guidance
- Faster clinical decisions through streamlined reporting and expert interpretation
- Expanded access to clinical trials based on tumor mutation profiling
- Improved patient outcomes through personalized, genomics-guided cancer care
Conçu pour :
- Oncologists
- Pathologists
- Cancer Patients
- Hospitals and Cancer Centers
- Researchers
- Healthcare Systems
Pourquoi choisir
DNA GTx ?
- Integration with multidisciplinary teams: Collaborative approach supporting oncologists, pathologists, and researchers.
- Robust bioinformatics: Advanced algorithms minimize false positives and enhance variant interpretation.
- Comprehensive data security: Ensures patient data confidentiality and compliance with data protection regulations.
- Rapid Sample Processing: Efficient workflows reduce sample handling time and potential degradation.
Oncology Test Panels
Séquençage clinique
Solutions for Researchers
Prise en charge prénatale
Médecine régénérative
Healthcare
Agriculture
Let’s Decode the Future of Health — Together
Get in touch today — let’s start a conversation that could change lives
*All information is handled with strict confidentiality.
Find Answers Today
Early detection saves lives
*All information is handled with strict confidentiality.
